2026 ICD-10-CM Diagnosis Code E74.21Galactosemia
ICD-10-CM Codes›E00–E89›E70-E88›E74
- Billable — Valid for Submission
- Chronic Condition
E74.21 is a billable ICD-10-CM diagnosis code for galactosemia. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified nutritional and metabolic disorders.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Classical galactosemia, heterozygous type
- Classical galactosemia, homozygous Duarte-type
- Classical galactosemia, homozygous Negro-type
- Deficiency of galactose mutarotase
- Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- Deficiency of UTP-hexose-1-phosphate uridylyltransferase
- Disorder of galactose metabolism
- Early neonatal jaundice due to galactosemia
- Erythrocyte uridine diphosphate galactose-4-epimerase deficiency
- Galactose epimerase deficiency
- Galactosemia
- Generalized uridine diphosphate galactose-4-epimerase deficiency
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Cataract (cortical) (immature) (incipient) - H26.9
- galactosemia - E74.21
- Galactosemia (classic) (congenital) - E74.21
- Jaundice (yellow) - R17
- galactosemia - E74.21
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Cataract(cortical) (immature) (incipient)
- associated with
- galactosemia
- Galactosemia(classic) (congenital)
- Jaundice(yellow)
- newborn
- due to or associated with
- galactosemia
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Galactokinase Deficiency|GALK Deficiency|Galactosemia Type 2
an autosomal recessive disorder caused by mutations in the galk1 gene. the disorder is characterized by an accumulation of galactose and galactitol secondary to the decreased conversion of galactose to galactose-1-phosphate by galactokinase. its major clinical symptom is the development of cataracts during the first weeks or months of life.Galactosemia
an autosomal recessive inherited metabolic disorder caused by mutations in the gale, galk1, and galt genes. it is characterized by deficiency of the enzymes responsible for the metabolism of galactose. signs and symptoms include intellectual disability, hepatomegaly, hepatic failure, and renal failure.Transferase Deficiency Galactosemia|Transferase Deficient Galactosemia|Transferase-deficient Galactosemia
a disorder characterized by the body's inability to metabolize galactose. this type of galactosemia is caused by germline mutations in the galt gene which leads to the inhibition in the activity of the enzyme galactose-1-phosphate uridyl transferase.
Patient EducationClinical
Carbohydrate Metabolism Disorders
Metabolism is the process your body uses to make energy from the food you eat. Food is made up of proteins, carbohydrates, and fats. Chemicals in your digestive system (enzymes) break the food parts down into sugars and acids, your body's fuel. Your body can use this fuel right away, or it can store the energy in your body tissues.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert E74.21 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About E74.21Overview
Is E74.21 (Disorders of galactose metabolism) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report galactosemia on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What is the ICD-9 equivalent of E74.21?
Under the General Equivalence Mappings, galactosemia converts to ICD-9-CM 271.1 (galactosemia). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
